STAND. COM. REP. NO. 1124-18

Honolulu, Hawaii

, 2018

RE: H.B. No. 2385

H.D. 2

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Judiciary, to which was referred H.B. No. 2385, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"

begs leave to report as follows:

The purpose of this measure is to update the list of Schedule 1 controlled substances of the State's Uniform Controlled Substances Act and make it consistent with the federal Controlled Substances Act as required by law.

The Department of Public Safety provided comments on this measure.

Your Committee has amended this measure by:

(1) Adding 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA), its optical, positional, and geometric isomers, salts and salts of isomers; also known as SGT-78, 4-CN-CUMYL-BINACA; CUMYL-CB-PINACA; CUMYL-CYBINACA; 4-cyano CUMYL-BUTINACA to the list of Schedule I drugs in Section 329-14, Hawaii Revised Statutes; and

(2) Adding Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] to the list of Schedule II drugs in Section 329-16, Hawaii Revised Statutes.

As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2385, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 2385, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Judiciary,

____________________________

SCOTT Y. NISHIMOTO, Chair